HLB Genex, Inc. (KOSDAQ:187420)

South Korea · Delayed Price · Currency is KRW

2,610.00

+435.00 (20.00%)

At close: Oct 8, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Enzyme/Material Business			25.50B	27.80B	25.87B	18.77B	14.94B
New Drug Development			1.51B	-	-	-	-
Total			27.01B	27.80B	25.87B	18.77B	14.94B

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
South Korea			18.36B	17.04B	18.40B	12.97B	10.45B
Netherlands			2.63B	4.61B	1.34B	-	-
China			-	-	-	1.79B	349.53M
USA			1.54B	1.78B	1.98B	1.70B	1.91B
UK			1.96B	1.44B	1.51B	-	-
Other			1.72B	2.93B	2.65B	2.31B	2.23B
Thailand			809.55M	-	-	-	-
Total			27.01B	27.80B	25.87B	18.77B	14.94B